-

12:55:39 PM

Latest ELTP Stock Market News

ELTP - Elite Pharmaceuticals, Inc.

06/14/21 5:10 PM

OTC : ELTP

Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2021 and Provides Conference Call Information

Elite Pharmaceuticals, Inc. ('Elite' or the "Company')(OTCBB:ELTP), a specialty pharmaceutical company developing niche generic products, announced results for the fiscal year ended March 31,

RHEA-AI

neutral

06/08/21 4:00 PM

OTC : ELTP

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Year-End Financial Results on June 15, 2021

Elite Pharmaceuticals, Inc. ('Elite' or the "Company') (OTCBB:ELTP), a specialty pharmaceutical company developing niche generic products, announced today that it will release

RHEA-AI

neutral

05/04/21 10:20 AM

OTC : ELTP

Elite Pharmaceuticals Enters into an Exclusive Distribution Agreement with Prasco, LLC and Announces Commercial Launch of Loxapine Capsules

Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced today that its distribution and marketing partner Prasco, LLC ("Prasco"), has launched Elite's generic Loxapine capsules. Elite entered a license, supply, and distribution

RHEA-AI

neutral

04/29/21 8:50 AM

OTC : ELTP

Elite Pharmaceuticals, Inc. Names Marc Bregman as Chief Financial Officer

Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing and manufacturing niche generic products, announced today that Marc Bregman, CPA, has been appointed as Chief Financial Officer (CFO),

RHEA-AI

neutral

02/16/21 4:35 PM

OTC : ELTP

Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2021 Ended December 31, 2020 and Provides Conference Call Information

Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing and manufacturing niche generic products, announced results for

RHEA-AI

neutral

02/10/21 7:00 AM

OTC : ELTP

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter of Fiscal Year 2021 Results on February 17, 2021

Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products,

RHEA-AI

neutral

11/24/20 6:30 AM

OTC : ELTP

Elite Pharmaceuticals, Inc. Issues Statement on Product Approval Listing

Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (OTCQB:ELTP) received inquiries about a recent ANDA approval listing for nifedipine under the company name of Elite Pharma. This ANDA approval is not a product developed by Elite. Elite's

RHEA-AI

neutral

11/16/20 4:25 PM

OTC : ELTP

Elite Pharmaceuticals, Inc. Reports Financial Results For The Second Quarter of Fiscal Year 2021 Ended September 30, 2020 and Provides Conference Call Information

Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP), a specialty pharmaceutical company developing and manufacturing niche generic products, announced results for the

RHEA-AI

neutral

08/14/20 4:30 PM

OTC : ELTP

Elite Pharmaceuticals, Inc. Reports Financial Results For The First Quarter Of Fiscal Year 2021 Ended June 30, 2020 And Provides Conference Call Information

Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing and manufacturing niche generic

RHEA-AI

neutral

08/12/20 5:20 PM

OTC : ELTP

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter of Fiscal Year 2021 Results on August 17, 2020

Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, announced

RHEA-AI

neutral